Developments in the identification of glycan biomarkers for the detection of cancer
about
Characterization of H type 1 and type 1 N-acetyllactosamine glycan epitopes on ovarian cancer specifically recognized by the anti-glycan monoclonal antibody mAb-A4.Serum glycopattern and Maackia amurensis lectin-II binding glycoproteins in autism spectrum disorderPolysialylated N-glycans identified in human serum through combined developments in sample preparation, separations, and electrospray ionization-mass spectrometry.Proteomics in veterinary medicine: applications and trends in disease pathogenesis and diagnostics.Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer.Modification of glycosylation mediates the invasive properties of murine hepatocarcinoma cell lines to lymph nodes.The Serum Immunoglobulin G Glycosylation Signature of Gastric CancerIdentification of 34 N-glycan isomers in human serum by capillary electrophoresis coupled with laser-induced fluorescence allows improving glycan biomarker discovery.Applications of Multiple Reaction Monitoring to Clinical Glycomics.Novel and emerging targeted-based cancer therapy agents and methods.Benchmark study of automatic annotation of MALDI-TOF N-glycan profiles.Tracking surface glycans on live cancer cells with single-molecule sensitivity.N-linked glycan profiling in neuroblastoma cell lines.Human Plasma N-glycosylation as Analyzed by Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance-MS Associates with Markers of Inflammation and Metabolic Health.MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues.Characteristic Changes in Cell Surface Glycosylation Accompany Intestinal Epithelial Cell (IEC) Differentiation: High Mannose Structures Dominate the Cell Surface Glycome of Undifferentiated Enterocytes.Differential N-Glycosylation Patterns in Lung Adenocarcinoma TissueSerum Glycans as Risk Markers for Non-Small Cell Lung Cancer.Global Identification and Differential Distribution Analysis of Glycans in Subcellular Fractions of Bladder CellsBiomarkers of Helicobacter pylori-associated gastric cancer.Direct analysis of aberrant glycosylation on haptoglobin in patients with gastric cancer.Relative versus absolute quantitation in disease glycomics.Quantification of tunicamycin-induced protein expression and N-glycosylation changes in yeast.Quantification of biopharmaceuticals and biomarkers in complex biological matrices: a comparison of liquid chromatography coupled to tandem mass spectrometry and ligand binding assays.Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis/cirrhosis diagnostics.Glycan-based diagnostic devices: current progress, challenges and perspectives.Glycans and glycoproteins as specific biomarkers for cancer.Chemical Glycoproteomics.Novel biomarkers for hepatocellular carcinoma surveillance: has the future arrived?Twoplex 12/13 C6 aniline stable isotope and linkage-specific sialic acid labeling 2D-LC-MS workflow for quantitative N-glycomics.LC-MS profiling of N-Glycans derived from human serum samples for biomarker discovery in hepatocellular carcinoma.Serum N-glycan analysis in breast cancer patients--Relation to tumour biology and clinical outcome.Liquid chromatography mass spectrometry-based O-glycomics to evaluate glycosylation alterations in gastric cancer.Visual detection of serum asialohaptoglobin by plasmonic sandwich ELLSA--a new platform for cirrhosis diagnosis.A method to identify trace sulfated IgG N-glycans as biomarkers for rheumatoid arthritis.A Multichannel Biosensor for Rapid Determination of Cell Surface Glycomic SignaturesThe Use of Multiple Reaction Monitoring on QQQ-MS for the Analysis of Protein- and Site-Specific Glycosylation Patterns in Serum.Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.Intramolecular glycosylation.Human disease glycomics: technology advances enabling protein glycosylation analysis - part 1.
P2860
Q33564920-D7CF872F-F95D-433A-AE9F-D46C642F6E5EQ33651921-9CB95533-B788-4507-B593-F00C44B3BB66Q34120306-5ED68706-221C-49F2-817B-9E3E887940B7Q34371926-2AE94CBB-44BD-42D6-8586-E01848192483Q34503577-0DA40DAD-2A2B-45A4-B440-0C7AFFB334C6Q34804402-DE4ECFBC-2200-422D-A904-DC123E1559CEQ35065968-74846E87-CF5B-4A63-925A-1DBB296DDDC7Q35262822-3DB04244-897E-45E8-BD3E-0F05EE62C708Q35447868-CE84F2AA-976A-4E8E-8CAA-6086BC9E9628Q35558057-3D8025A8-314E-4F8F-BB65-0B7B69202387Q35654789-6BB859EA-4E38-451A-929A-F6D6C0A0AA79Q35738212-DEA7D972-A613-4024-A62B-299C49920127Q35892304-45BD7FE3-5A62-4A31-8FA2-913590271D59Q36216763-A6B23C04-7061-462D-9F3E-2579B8C52BF1Q36256730-994C0307-26D3-4A70-9A3F-2D1DA5E05081Q36263012-8DEA7277-0D95-4655-A939-E7DAC55E6398Q36278033-05DB5792-4C1D-4564-840B-660BFD990E40Q36759054-DDBDCC6D-C419-49A9-8E39-E8F06576824DQ37012115-AC446CB6-AEC8-4E36-B2BF-B4D50B23064BQ37591506-EBCD9603-F471-4406-93C1-F8EE9DEA259BQ37706879-D6A1FEDA-D6DF-488F-B056-8AEC165E8B59Q38356585-CBB84EB4-0E45-4E67-8549-4287FB57F87DQ38449518-F253C6FC-E9F7-4D90-81F7-57DD80F27A96Q38500988-96636AFF-3C35-49F9-905C-2C0A504F7F9FQ38591154-8FDD8173-1E47-4714-A330-77EA6C636F7AQ38595689-A6B7DFAF-5AF6-4C54-84D5-BFACC828A616Q38945184-CDD630B3-056B-4321-BBB4-2C8F299E2DBAQ39037656-93DE6083-BFBC-4278-B1C9-DBB134E576FFQ39062912-3687CA86-FBFB-48BE-ABA0-09A2274D39B0Q39149624-D8311ABC-5EB1-4342-8728-0A79225BB2B3Q39535354-EC5A3725-23FF-4BFC-A8CC-4BBC6E808981Q40592492-36AF1CD3-B9F4-42A7-86BF-3A5735D6432EQ40644424-6F102387-9710-44CB-9EA1-EAD8D5283F4BQ41123248-8522CFF7-BF69-42E6-B3A3-A4562CC3218CQ41701035-8A00B969-8ED2-4AF9-8D5D-45FA445F4B48Q42583971-A9ED8E8F-CC1B-4CC0-8B96-35B9BD7184EBQ43677119-C3075872-FB7F-433B-BE05-7BADC09FC1C2Q45072735-0AC5F31C-A6FD-46AA-9450-F01A6E52F558Q47136550-57B1F6AB-D745-4B3D-BC16-D967F95A40D8Q47212798-C97DDE36-1894-46FB-B342-BE188CC32B61
P2860
Developments in the identification of glycan biomarkers for the detection of cancer
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Developments in the identification of glycan biomarkers for the detection of cancer
@ast
Developments in the identification of glycan biomarkers for the detection of cancer
@en
Developments in the identification of glycan biomarkers for the detection of cancer
@nl
type
label
Developments in the identification of glycan biomarkers for the detection of cancer
@ast
Developments in the identification of glycan biomarkers for the detection of cancer
@en
Developments in the identification of glycan biomarkers for the detection of cancer
@nl
prefLabel
Developments in the identification of glycan biomarkers for the detection of cancer
@ast
Developments in the identification of glycan biomarkers for the detection of cancer
@en
Developments in the identification of glycan biomarkers for the detection of cancer
@nl
P2860
P921
P3181
P356
P1476
Developments in the identification of glycan biomarkers for the detection of cancer
@en
P2093
Carlito B Lebrilla
Suzanne Miyamoto
P2860
P304
P3181
P356
10.1074/MCP.R112.026799
P407
P5008
P577
2013-01-30T00:00:00Z